Satellos Bioscience Stock Price, News & Analysis
Company Description
Satellos Bioscience (NASDAQ: MSLE) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $122.5M, ranking #5,049 among all listed U.S. companies by market cap.
MSLE stock has declined 48.9% over the past year. Shares last traded at $5.90.
On a trailing twelve-month basis, Satellos Bioscience reported net income of -$24.9M.
This page provides a comprehensive overview of MSLE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Satellos Bioscience (MSLE) stock last traded at $5.90, down 2.88% from the previous close. Over the past 12 months, the stock has lost 48.9%. At a market capitalization of $122.5M, MSLE is classified as a micro-cap stock with approximately 20.8M shares outstanding.
MSLE Rankings
Latest News
Satellos Bioscience has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include conferences, earnings, clinical trial. View all MSLE news →
SEC Filings
Satellos Bioscience has filed 5 recent SEC filings, including 3 Form 6-K, 2 Form SCHEDULE 13G. The most recent filing was submitted on May 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all MSLE SEC filings →
Financial Highlights
net income was -$24.9M. The company generated -$23.6M in operating cash flow. With a current ratio of 7.77, the balance sheet reflects a strong liquidity position.
Upcoming Events
BASECAMP enrollment completion
Satellos Bioscience has 1 upcoming scheduled event. The next event, "BASECAMP enrollment completion", is scheduled for July 1, 2026 (in 18 days). Investors can track these dates to stay informed about potential catalysts that may affect the MSLE stock price.
Short Interest History
Short interest in Satellos Bioscience (MSLE) currently stands at 95.8 thousand shares, up 21.4% from the previous reporting period, representing 0.5% of the float. Over the past 12 months, short interest has increased by 1333.1%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Satellos Bioscience (MSLE) currently stands at 1.9 days, up 75.5% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 93% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.9 days.
MSLE Company Profile & Sector Positioning
Satellos Bioscience (MSLE) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ. In monthly performance, the stock ranks #4,118 among all tracked companies.